These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

102 related articles for article (PubMed ID: 1706862)

  • 21. Selective activation of mesolimbic and mesocortical dopamine metabolism in rat brain by infusion of a stable substance P analogue into the ventral tegmental area.
    Elliott PJ; Alpert JE; Bannon MJ; Iversen SD
    Brain Res; 1986 Jan; 363(1):145-7. PubMed ID: 2418910
    [TBL] [Abstract][Full Text] [Related]  

  • 22. The response of non-dopamine neurons in substantia nigra and ventral tegmental area to amphetamine and apomorphine during hypermotility: the striatal influence.
    Olds ME
    Brain Res; 1988 Jun; 452(1-2):237-54. PubMed ID: 3401732
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Pressor responses to electrical and chemical stimulation of the rat brain A10 dopaminergic system.
    Cornish JL; van den Buuse M
    Neurosci Lett; 1994 Aug; 176(2):142-6. PubMed ID: 7530350
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Substance K, a novel tachykinin injected bilaterally into the ventral tegmental area of rats increases behavioral response.
    Takano Y; Takeda Y; Yamada K; Kamiya H
    Life Sci; 1985 Dec; 37(26):2507-14. PubMed ID: 2417083
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Behavioural consequences following infusion of selective neurokinin agonists into the median raphe nucleus of the rat.
    Mason GS; Elliott PJ
    Neuropharmacology; 1992 Aug; 31(8):757-60. PubMed ID: 1382245
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Magnitude and duration of hyperactivity following neonatal 6-hydroxydopamine is related to the extent of brain dopamine depletion.
    Miller FE; Heffner TG; Kotake C; Seiden LS
    Brain Res; 1981 Dec; 229(1):123-32. PubMed ID: 6796194
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Correlation between the discharge rate of non-dopamine neurons in substantia nigra and ventral tegmental area and the motor activity induced by apomorphine.
    Olds ME
    Neuroscience; 1988 Feb; 24(2):465-76. PubMed ID: 3362349
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Neurochemical and behavioral effects of corticotropin-releasing factor in the ventral tegmental area of the rat.
    Kalivas PW; Duffy P; Latimer LG
    J Pharmacol Exp Ther; 1987 Sep; 242(3):757-63. PubMed ID: 3498816
    [TBL] [Abstract][Full Text] [Related]  

  • 29. The NK-3 tachykinin agonist senktide elicits yawning and chewing mouth movements following subcutaneous administration in the rat. Evidence for cholinergic mediation.
    Stoessl AJ; Dourish CT; Iversen SD
    Psychopharmacology (Berl); 1988; 95(4):502-6. PubMed ID: 2463651
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Intra-raphe muscimol induced hyperactivity depends on ascending serotonin projections.
    Sainati SM; Lorens SA
    Pharmacol Biochem Behav; 1982 Nov; 17(5):973-86. PubMed ID: 6294690
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Behavioural activation induced in the rat by substance P infusion into ventral tegmental area: implication of dopaminergic A10 neurones.
    Kelley AE; Stinus L; Iversen SD
    Neurosci Lett; 1979 Mar; 11(3):335-9. PubMed ID: 514544
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Transmitter release from transplants of fetal ventral mesencephalon or locus coeruleus in the rat frontal cortex and nucleus accumbens: effects of pharmacological and behaviorally activating stimuli.
    Cenci MA; Kalén P; Duan WM; Björklund A
    Brain Res; 1994 Apr; 641(2):225-48. PubMed ID: 8012825
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Locomotor activation induced by MK-801 in the rat: postsynaptic interactions with dopamine receptors in the ventral striatum.
    Ouagazzal A; Nieoullon A; Amalric M
    Eur J Pharmacol; 1994 Jan; 251(2-3):229-36. PubMed ID: 8149978
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Mesolimbic dopamine mediates gastric mucosal protection by central neurotensin.
    Xing LP; Balaban C; Seaton J; Washington J; Kauffman G
    Am J Physiol; 1991 Jan; 260(1 Pt 1):G34-8. PubMed ID: 1899007
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Behavioral effects of a dimethylsulfonium analog of dopamine after injection into the nucleus accumbens and the striatum.
    Boldry R; Chang Y; Miller DD; Uretsky NJ
    Pharmacol Biochem Behav; 1986 Feb; 24(2):223-8. PubMed ID: 3081914
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Nicotine injections into the ventral tegmental area increase locomotion and Fos-like immunoreactivity in the nucleus accumbens of the rat.
    Panagis G; Nisell M; Nomikos GG; Chergui K; Svensson TH
    Brain Res; 1996 Aug; 730(1-2):133-42. PubMed ID: 8883897
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Injections of 6-hydroxydopamine into the ventral tegmental area destroy mesolimbic dopamine neurons but spare the locomotor activating effects of nicotine in the rat.
    Vezina P; Hervé D; Glowinski J; Tassin JP
    Neurosci Lett; 1994 Feb; 168(1-2):111-4. PubMed ID: 8028761
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Effect of 6-hydroxydopamine-induced lesions of A10 dopaminergic neurons on aggressive behavior in rats.
    Puciłowski O; Kostowski W; Bidziński A; Hauptmann M
    Pharmacol Biochem Behav; 1982 Apr; 16(4):547-51. PubMed ID: 6803251
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Positively reinforcing effects of the neurokinin substance P in the basal forebrain: mediation by its C-terminal sequence.
    Hasenöhrl RU; Gerhardt P; Huston JP
    Exp Neurol; 1992 Feb; 115(2):282-91. PubMed ID: 1370940
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Suggestive evidence for inhibitory effects of galanin on mesolimbic dopaminergic neurotransmission.
    Ericson E; Ahlenius S
    Brain Res; 1999 Mar; 822(1-2):200-9. PubMed ID: 10082897
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.